CN101492430B - 一种高纯度盐酸西替利嗪的制备方法 - Google Patents
一种高纯度盐酸西替利嗪的制备方法 Download PDFInfo
- Publication number
- CN101492430B CN101492430B CN2009100965583A CN200910096558A CN101492430B CN 101492430 B CN101492430 B CN 101492430B CN 2009100965583 A CN2009100965583 A CN 2009100965583A CN 200910096558 A CN200910096558 A CN 200910096558A CN 101492430 B CN101492430 B CN 101492430B
- Authority
- CN
- China
- Prior art keywords
- add
- reaction
- filtrate
- cetirizine
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 23
- 229960004342 cetirizine hydrochloride Drugs 0.000 title abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 37
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229960001803 cetirizine Drugs 0.000 claims abstract description 15
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 claims abstract description 15
- 238000006482 condensation reaction Methods 0.000 claims abstract description 14
- 239000007789 gas Substances 0.000 claims abstract description 14
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000003960 organic solvent Substances 0.000 claims abstract description 6
- 239000000758 substrate Substances 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 68
- 238000003756 stirring Methods 0.000 claims description 50
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 39
- 239000000706 filtrate Substances 0.000 claims description 36
- 238000000605 extraction Methods 0.000 claims description 28
- 150000003839 salts Chemical class 0.000 claims description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 20
- 239000010410 layer Substances 0.000 claims description 20
- 239000012044 organic layer Substances 0.000 claims description 20
- -1 4-chloro-phenyl- Chemical group 0.000 claims description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000000967 suction filtration Methods 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 15
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 14
- HTGCVLNFLVVCST-UHFFFAOYSA-N 1-piperazin-1-ylethanol Chemical compound CC(O)N1CCNCC1 HTGCVLNFLVVCST-UHFFFAOYSA-N 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 238000004140 cleaning Methods 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 10
- 239000012065 filter cake Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000003610 charcoal Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 230000000630 rising effect Effects 0.000 claims description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 3
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 claims description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 2
- GHVZOJONCUEWAV-UHFFFAOYSA-N [K].CCO Chemical compound [K].CCO GHVZOJONCUEWAV-UHFFFAOYSA-N 0.000 claims description 2
- 229960001701 chloroform Drugs 0.000 claims description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 239000002994 raw material Substances 0.000 abstract description 12
- 239000003054 catalyst Substances 0.000 abstract description 3
- 239000002699 waste material Substances 0.000 abstract description 2
- ZLYGTXIQYQLAGA-UHFFFAOYSA-N 1-[4-[2-(4-chlorophenyl)phenyl]piperazin-1-yl]ethanol Chemical compound ClC1=CC=C(C=C1)C1=C(C=CC=C1)N1CCN(CC1)C(C)O ZLYGTXIQYQLAGA-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 13
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 5
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 2
- 238000003810 ethyl acetate extraction Methods 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 1
- UGVRJVHOJNYEHR-UHFFFAOYSA-N 4-chlorobenzophenone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1=CC=CC=C1 UGVRJVHOJNYEHR-UHFFFAOYSA-N 0.000 description 1
- 102000003834 Histamine H1 Receptors Human genes 0.000 description 1
- 108090000110 Histamine H1 Receptors Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- IHTYTYHXCRAMAV-UHFFFAOYSA-N acetic acid;dihydrochloride Chemical compound Cl.Cl.CC(O)=O IHTYTYHXCRAMAV-UHFFFAOYSA-N 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000938 histamine H1 antagonist Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100965583A CN101492430B (zh) | 2009-03-06 | 2009-03-06 | 一种高纯度盐酸西替利嗪的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100965583A CN101492430B (zh) | 2009-03-06 | 2009-03-06 | 一种高纯度盐酸西替利嗪的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101492430A CN101492430A (zh) | 2009-07-29 |
CN101492430B true CN101492430B (zh) | 2011-04-20 |
Family
ID=40923241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100965583A Active CN101492430B (zh) | 2009-03-06 | 2009-03-06 | 一种高纯度盐酸西替利嗪的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101492430B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102321047B (zh) * | 2011-07-19 | 2013-09-18 | 浙江浙北药业有限公司 | 一种盐酸西替利嗪的制备方法 |
CN104130211B (zh) * | 2013-05-03 | 2016-04-13 | 重庆沃肯精细化工有限公司 | 一种合成盐酸西替利嗪的工艺 |
CN103497166A (zh) * | 2013-09-27 | 2014-01-08 | 盐城格瑞茵化工有限公司 | 一种盐酸西替利嗪中间体的合成方法 |
CN113861131B (zh) * | 2021-11-08 | 2024-04-19 | 深圳菲斯生物科技有限公司 | 一种西替利嗪杂质c的制备方法 |
-
2009
- 2009-03-06 CN CN2009100965583A patent/CN101492430B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101492430A (zh) | 2009-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105622609B (zh) | 一种利格列汀的制备方法 | |
CN105061414B (zh) | 一锅法制备Brexpiprazole | |
CN101492430B (zh) | 一种高纯度盐酸西替利嗪的制备方法 | |
CN102295638A (zh) | 拉帕替尼的新制备方法 | |
CN112079848A (zh) | 巴洛沙韦关键中间体的合成方法 | |
CN107337675A (zh) | 一种制备替格瑞洛的改进方法 | |
CN113968828B (zh) | 一种4-(6-氨基吡啶-3-基)哌嗪-1-羧酸叔丁酯的合成方法 | |
CN102584693B (zh) | 一种高纯度2-氯-3-氨基吡啶盐酸盐的制备方法 | |
CN103980134B (zh) | 一种琥珀酸s-美托洛尔的制备方法 | |
CN102617460A (zh) | 一种合成孟鲁司特钠所需中间体的合成方法 | |
CN101531634B (zh) | 一种高纯度的布南色林及其制备方法 | |
CN111675710B (zh) | 度维尼西的制备方法 | |
CN103242291A (zh) | 一种多晶型高含量苯甲酸阿格列汀的批量生产工艺 | |
CN103224476A (zh) | 二乙醇胺法制备1-[2-(2-羟基乙氧基)乙基]哌嗪新工艺 | |
CN106674135A (zh) | 一种合成尿嘧啶的方法 | |
CN109836425B (zh) | 一种合成培美酸的制备工艺 | |
CN101955459A (zh) | 一种布南色林的制备方法 | |
CN109053585B (zh) | 一种三氯苯达唑的合成方法 | |
CN102603521A (zh) | 一种2,3,4,5-四氟苯甲酰氯的制备方法 | |
CN106632347B (zh) | 一种吡咯并吡嗪化合物及其盐的制备方法 | |
CN108129525B (zh) | 一种依托泊苷中间体的制备方法 | |
CN112694436B (zh) | 一种槟榔碱的合成方法 | |
CN113024454B (zh) | 一种布格替尼中间体的合成方法 | |
CN101747293B (zh) | 萘哌地尔的制备方法 | |
CN116496234B (zh) | 一种盐酸乌拉地尔关键中间体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HANGZHOU HEZE PHARMACEUTICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HANGZHOU HEXO CHEMICAL TECHNOLOGY CO., LTD. Effective date: 20120409 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 311200 HANGZHOU, ZHEJIANG PROVINCE TO: 310018 HANGZHOU, ZHEJIANG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120409 Address after: 310018 room 452, No. 6, main street, Xiasha economic and Technological Development Zone, Hangzhou, Zhejiang, Patentee after: HANGZHOU HEZE PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Address before: 311200, room 2, building 16, block 626, Xiasha Economic Development Zone, Hangzhou, Zhejiang Patentee before: HEXO CHEMTECH Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: Room 201, building 4, No. 101, No. 1 Street, Qiantang New District, Hangzhou City, Zhejiang Province Patentee after: Zhejiang Heze Pharmaceutical Technology Co.,Ltd. Address before: 310018 room 452, No. 6, main street, Xiasha economic and Technological Development Zone, Hangzhou, Zhejiang, Patentee before: HANGZHOU HEZE PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230922 Address after: 5th Floor, Research Building, No. 10 Shennong Road, Torch Development Zone, Zhongshan City, Guangdong Province, 528437 Patentee after: Guangdong Yueheze Pharmaceutical Research Co.,Ltd. Patentee after: Zhejiang Heze Pharmaceutical Technology Co.,Ltd. Address before: Room 201, building 4, No. 101, No. 1 Street, Qiantang New District, Hangzhou City, Zhejiang Province Patentee before: Zhejiang Heze Pharmaceutical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |